Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report specifically details a transaction in own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 865,652 ordinary shares
- Purchase Date: April 14, 2025
- Lowest Price Paid: £3.7420 per share
- Highest Price Paid: £3.7960 per share
- Volume Weighted Average Price: £3.7657 per share
- Post-Transaction Share Capital: 9,029,557,071 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,025,476,866
Material Changes
The primary material change is the reduction of outstanding voting shares following the cancellation of 865,652 shares purchased on April 14, 2025. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It serves strictly as a regulatory disclosure of a specific share transaction in compliance with the Market Abuse Regulation.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the March 28, 2025 buyback programme.
- Confirm the updated number of voting shares (9,025,476,866) for disclosure threshold calculations under FCA rules.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction details.
- Note that this filing does not contain financial performance results; refer to Form 20-F for comprehensive financial data.